(Q43903850)

27 November 2017

title

Is topiramate effective for weight loss in neuroleptic-induced obesity? 2 case reports (English)

1 reference

27 November 2017

0 references

2

J Hebebrand

1 reference

27 November 2017

4

H Remschmidt

1 reference

27 November 2017

M Schüler-Springorum

1

1 reference

27 November 2017

P M Wehmeier

series ordinal

3

1 reference

27 November 2017

language of work or name

German

0 references

publication date

1 February 2002

1 reference

Zeitschrift fuer Kinder- und Jugendpsychiatrie und Psychotherapie

27 November 2017

published in

1 reference

27 November 2017

volume

30

1 reference

27 November 2017

issue

1

1 reference

27 November 2017

page(s)

51-58

1 reference

Weight gain associated with valproate in childhood

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1024%2F%2F1422-4917.30.1.51

7 January 2021

Accelerated weight loss after treating refractory depression with fluoxetine plus topiramate: possible mechanisms of action?

1 reference

https://api.crossref.org/works/10.1024%2F%2F1422-4917.30.1.51

7 January 2021

https://api.crossref.org/works/10.1024%2F%2F1422-4917.30.1.51

1 reference

7 January 2021

Mood stabilization and weight loss with topiramate

1 reference

https://api.crossref.org/works/10.1024%2F%2F1422-4917.30.1.51

7 January 2021

Adverse effects of antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1024%2F%2F1422-4917.30.1.51

7 January 2021

Use of topiramate, a new anti-epileptic as a mood stabilizer

1 reference

https://api.crossref.org/works/10.1024%2F%2F1422-4917.30.1.51

7 January 2021

Open-label adjunctive topiramate in the treatment of bipolar disorders.

1 reference

https://api.crossref.org/works/10.1024%2F%2F1422-4917.30.1.51

7 January 2021

Topiramate as add-on treatment for patients with bipolar mania

1 reference

https://api.crossref.org/works/10.1024%2F%2F1422-4917.30.1.51

7 January 2021

Topiramate: preclinical evaluation of structurally novel anticonvulsant.

1 reference

https://api.crossref.org/works/10.1024%2F%2F1422-4917.30.1.51

7 January 2021

Safety of topiramate: adverse events and relationships to dosing

1 reference

https://api.crossref.org/works/10.1024%2F%2F1422-4917.30.1.51

7 January 2021

Lateral hypothalamic injections of glutamate, kainic acid,d,l-α-amino-3-hydroxy-5-methyl-isoxazole propionic acid or N-methyl-d-aspartic acid rapidly elicit intense transient eating in rats

1 reference

https://api.crossref.org/works/10.1024%2F%2F1422-4917.30.1.51

7 January 2021

10.1024//1422-4917.30.1.51

Identifiers

DOI

1 reference

27 November 2017

1 reference